Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
September 30, 2026 55.37M
June 30, 2026 53.70M
Date Value
March 31, 2026 46.20M
December 31, 2025 37.80M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Anavex Life Sciences Corp. 11.44M
Vaxcyte, Inc. 1.093B
Foghorn Therapeutics, Inc. 76.22M
Caribou Biosciences, Inc. 84.72M
Oncolytics Biotech, Inc. 13.18M